SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-001469
Filing Date
2020-02-26
Accepted
2020-02-26 16:12:12
Documents
14
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20200226x8k68c54ef.htm   iXBRL 8-K 35247
2 EX-99.1 ex-99d1.htm EX-99.1 155064
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 2270
  Complete submission text file 0001558370-20-001469.txt   324688

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20200226.xsd EX-101.SCH 3052
5 EX-101.LAB edit-20200226_lab.xml EX-101.LAB 15384
6 EX-101.PRE edit-20200226_pre.xml EX-101.PRE 9975
8 EXTRACTED XBRL INSTANCE DOCUMENT edit-20200226x8k68c54ef_htm.xml XML 4678
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 20655796
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences